Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Exercise or conversion President, MWH acquired 1,307 shares (option exercise)
  2. 4 Open-market buy Director bought 5,860 shares at $25.60 ($149,998)
  3. 4 Grant or award Director acquired 11,687 shares (grant or award)
  4. 4 Grant or award Director acquired 11,687 shares (grant or award)
  5. 4 Grant or award Director acquired 11,687 shares (grant or award)
  6. 4 Grant or award Director acquired 11,687 shares (grant or award)
  7. 4 Grant or award Director acquired 11,687 shares (grant or award)
  8. 4 Grant or award Director acquired 11,687 shares (grant or award)
  9. 4 Grant or award Director acquired 11,687 shares (grant or award)
  10. 4 Grant or award Director acquired 11,687 shares (grant or award)
  11. 4 Open-market buy Director bought 7,000 shares at $23.46 ($164,223)
  12. 4 Returned to the company Exec. VP International Ops returned 7,153 shares (to the company)
  13. 4 Returned to the company Chief Financial Officer returned 11,942 shares (to the company)
  14. 4 Returned to the company President Crescendo BioScience returned 11,107 shares (to the company)
  15. 4 Returned to the company E.V.P., General Counsel returned 833 shares (to the company)
  16. 4 Returned to the company President Myriad RBM, Inc. returned 5,313 shares (to the company)
  17. 4 Returned to the company President Assurex Health Inc. returned 725 shares (to the company)
  18. 4 Returned to the company President, MWH returned 8,483 shares (to the company)
  19. 4 Returned to the company Chief Scientific Officer returned 10,701 shares (to the company)
  20. 4 Returned to the company President, MGL returned 1,182 shares (to the company)

Page 23 of 65 · 1,294 filings